K Pharma Inc. (4896)
JPX JPX Primary Summary
K Pharma Inc. (4896) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has K Pharma Inc. ever had a stock split?
K Pharma Inc. Profile
| Biotechnology Industry | Healthcare Sector | - CEO | JPX Exchange | JP3280900006 ISIN |
| Japan Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
K Pharma, Inc. is a biopharmaceutical company that operates within Japan, focusing on the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products. The organization leverages advanced disease-specific induced pluripotent stem (iPS) cell technology for the creation of innovative treatments for spinal cord injuries and cerebral infarctions. Since its incorporation in 2016, K Pharma, Inc. has established its headquarters in Minato, Japan, emphasizing its commitment to addressing unmet medical needs through pioneering scientific approaches.
Products and Services
- Regenerative Medicine for Spinal Cord Injuries:
This product line utilizes cutting-edge iPS cell technology to develop therapies aimed at repairing nerve damage caused by spinal cord injuries. By focusing on regenerating the damaged nerve cells, K Pharma, Inc. aims to restore function and improve the quality of life for patients suffering from such debilitating conditions.
- Regenerative Medicine for Cerebral Infarctions:
Exploiting the same iPS cell technology, the company is developing treatments specifically for cerebral infarctions, otherwise known as strokes. This innovative approach seeks to regenerate brain tissue damaged during a stroke, potentially offering a new lease on life for stroke survivors by enhancing recovery and functionality.
